Biphasic dose response in low level light therapy - an update.
Level 5 - mechanism / opinion, no new human data
Narrative review of preclinical in vitro and animal studies without systematic methodology
PubMed 22461763 · doi:10.2203/dose-response.11-009.Hamblin
What was done
This narrative review updates prior work evaluating biphasic dose responses (Arndt-Schulz curves) in low-level light therapy (LLLT). The authors synthesized evidence from in vitro cellular assays and animal models, including mouse studies of transcranial LLLT for traumatic brain injury.
What was found
The abstract provides no numerical data. It reports qualitative patterns: in vitro markers including adenosine triphosphate (ATP) and mitochondrial membrane potential exhibit biphasic responses to light dose, while mitochondrial reactive oxygen species (ROS) show a triphasic response with two separate peaks. In mouse traumatic brain injury models, beneficial neurological outcomes followed a biphasic curve when varying either treatment frequency or energy density per session.
Why it matters
Highlights that biological responses to photobiomodulation are non-linear, which may explain why inappropriate dosing choices lead to negative or conflicting experimental outcomes.
Limits
The review relies entirely on preclinical bench and mouse data, with no direct human clinical evidence presented in the abstract. No quantitative effect sizes, confidence intervals, or formal systematic search criteria are described.
Cited by
- supports A 2009 study showed that low to moderate doses of light stimulate mitochondria to produce ATP and a small burst of reactive oxygen species to trigger cellular repair, whereas excessive doses generate massive reactive oxygen species that shut down mitochondrial respiration and induce apoptosis.